Company intelligence / Profile preview

Bare

Leverkusen, North Rhine-Westphalia, Germanybarehome.com ↗

Ownership: Private
Employees: ~92815
Development stage: Other

Overview

Bayer is one of the world’s largest pharmaceutical and biotechnology companies with over 160 years in operation. It develops and markets prescription drugs (notably in cardiology, oncology, hematology), consumer health products (such as Aspirin), agricultural chemicals/seeds via its Crop Science division (including Monsanto acquisition), and animal health solutions. Its clinical portfolio includes numerous approved drugs as well as ongoing development programs across major therapeutic areas[2][3][4][5].

Modalities: Small moleculeMonoclonal antibodyBiologicRecombinant proteinDevice/Hormone combination
Industry: Pharma

Beyond the preview

Go deeper on Bare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bare.

Explore the full profile